National Human Genome Research Institute

CBC on Virtual Tour: Precision Breast Cancer Medicine

Wed 10 November 2021

Join Professor Jean Abraham to hear how combining cutting-edge research into different types of breast cancer with clinical trials aims to deliver more precise treatment for individual patients.
Professor Jean Abraham is an Academic Honorary Consultant in Medical Oncology and Professor of Precision Breast Cancer Medicine at the University of Cambridge. As well as treating breast cancer patients in clinic and conducting clinical research, she is Director of the Cambridge Breast Cancer Unit at Addenbrooke’s and co-leads the Integrated Cancer Medicine Programme at the Cancer Research UK Cambridge Centre.
Jean has a particular interest in the management and treatment of high risk and hereditary breast cancers. She is actively involved in the design and development of biomarker directed clinical trials which aim to treat patients in a more targeted fashion with fewer side effects, earlier in their treatment pathway. She also co-leads the pioneering Personalised Breast Cancer Programme which reads tumour DNA and RNA information like a barcode to tailor treatment for breast cancer patients. The Programme has enrolled over 800 breast cancer patients at Addenbrooke’s and has recently opened in Oxford.
Jean graduated from the University of Liverpool Medical School then completed her training in General Medicine and Oncology in Cambridge. She was awarded a Cancer Research UK National Clinical Training Fellowship and has a PhD in pharmacogenetics from the University of Cambridge.
This event is part of the ‘CBC on Virtual Tour’ series – the chance to learn more about the Cambridge Biomedical Campus where over 20,000 people at the forefront of the changing face of healthcare are working.
This event will be recorded and a link will be sent to all participants afterwards. It will also be posted on the CUHP website and the Cambridge Biomedical Campus YouTube channel.
Photo credit: National Human Genome Research Institute

Cost: FOC